Stelvio Therapeutics

Developing therapies through epigenetics

Company Details

Stelvio Therapeutics is developing therapies through epigenetics.

We have invented a novel platform screening technology called Microscopic Imaging of Epigenetic Landscape (MIEL) which uses machine learning to identify novel therapeutics for cancer and neurodegenerative diseases, such as Huntington’s.

Our team has core competencies of scientific creativity, clinical excellence and professional management required to successfully commercialize novel drug therapies and precision medicine diagnostics.

Company People

Attila Hajdu

Attila Hajdu
CEO & Founder

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.